glp 1 drugs adverse effects GLP-1 nausea: How to handle GLP-1s' most common side effect It's Not an Overdose: The
Description
The EMA stated that NAION may affect up to 1 in 10,000 people taking semaglutide and recommended that semaglutide treatment be stopped if NAION is confirmed

Gender difference in cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in type 2 diabetes: a systematic review and meta-analysis of cardio-vascular outcome trials

GLP-1R, glucagon-like peptide-1 receptor
Ornelas C, Caiado J, Lopes A, Pereira Dos Santos MC, Pereira BM

Based on these findings, GLP-1 agonists, which are commonly used for weight management and diabetes, may be associated with lower breast cancer incidence among women

However, no cause-effect association between the use of GLP-1 receptor agonists and more serious infections has been observed
